Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:48 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | LYTTON LAURENCE W | 11,900 0.1% | -3,113,822 (-99.62%) | View |
| 2023-02-14 3:32 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | Lung Therapeutics Inc. | 773,000 2.1% | -1,462,000 (-65.41%) | View |
| 2023-02-13 4:03 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | LYTTON LAURENCE W | 3,125,722 8.4% | -11,919 (-0.38%) | View |
| 2023-02-09 4:30 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | CARLSON CAPITAL L P | 1,842,000 5.1% | -352,000 (-16.04%) | View |
| 2022-11-28 4:17 pm Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | CARLSON CAPITAL L P | 2,194,000 6.2% | 2,194,000 (New Position) | View |
| 2022-11-23 1:01 pm Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | LYTTON LAURENCE W | 3,137,641 8.8% | 3,137,641 (New Position) | View |
| 2022-02-14 4:10 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | Corriente Advisors LLC | 0 0% | -1,350,000 (Position Closed) | View |
| 2022-02-14 3:07 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | Lung Therapeutics Inc. | 2,235,000 8.81% | -715,000 (-24.24%) | View |
| 2022-02-14 08:24 am Sale | 13G | TFF PHARMACEUTICALS INC TFFP | Nantahala Capital Management LLC | 0 0% | -1,763,476 (Position Closed) | View |
| 2021-02-16 06:33 am Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | Corriente Advisors LLC | 1,350,000 6.07% | 1,350,000 (New Position) | View |
| 2021-02-16 06:25 am Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | Nantahala Capital Management LLC | 1,763,476 7.9% | 1,763,476 (New Position) | View |
| 2021-02-03 3:10 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | Lung Therapeutics Inc. | 2,950,000 13.3% | -1,050,000 (-26.25%) | View |
| 2020-02-03 12:42 pm Purchase | 13G | TFF PHARMACEUTICALS INC TFFP | Lung Therapeutics Inc. | 4,000,000 21.7% | 4,000,000 (New Position) | View |